Targeting the Lnc-OPHN1-5/androgen receptor/hnRNPA1 complex increases Enzalutamide sensitivity to better suppress prostate cancer progression

Meng Zhang(Scripps Research Institute), Chawnshang Chang(China Medical University)
Cell Death and Disease
September 20, 2021
Cited by 17


Related Papers